Skip to content

Tele-Prehabilitation of out-patients before major abdominal surgery

Tele-Prehabilitation of out-patients before major abdominal surgery - Tele-Prehab

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033409
Enrollment
70
Registered
2024-05-27
Start date
2025-02-07
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z51.4

Interventions

Group 1: Control group: standard of care Group 2: Intervention group: mutimodal prehabilitation supported by telemedicine from study inclusion until elective surgery: Standard care + multimodal preope

Sponsors

Uniklinik RWTH Aachen, Klinik für Anästhesiologie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Given informed consent 2. Adult patients (= 18 years) 3. Elective major abdominal surgery defined by expected ICU stay =24 hours 4. Surgery scheduled in = 10 days 5. Increased perioperative risk as defined by at least one of the following: a. Age =60 years b. Risk of or with established malnutrition (GLIM criteria stage 1 or 2) c. Risk of or with established sarcopenia (EWGSOP2 criteria = 2) d. Risk of or with established frailty (Clinical Frailty Scale =4)

Exclusion criteria

Exclusion criteria: • Patients < 18 years, pregnant or lactating patients • Patients unable to consent (cognitive, psychiatric, or severe language barriers) • < 10 days until elective surgery • Death expected within 3 months after screening due to severity of disease • Patients already receiving medical nutrition therapy at home (oral, enteral or parenteral nutrition) • Patients unable to follow orders from the study personnel • Technical barriers preventing tele-prehabilitation • Affected motor function or extremity impairments preventing the intervention or outcome assessment • Full enteral nutrition is contraindicated • Uncontrolled diabetes mellitus • Clinical fulminant hepatic failure or Cirrhosis Child’s Class C Liver Disease • Severely reduced kidney function • Known allergy/ intolerance to study nutrients • Enrolment in an industry sponsored randomized trial within the last 30 days (co-enrolment in academic randomized trials will be considered on a case-by-case basis)

Design outcomes

Primary

MeasureTime frame
Feasibility of the study protocol as determined by: •Technical feasibility: To determine if teleconsultation is feasible in this patient group oLow major technical difficulties: <10% (major difficulties are defined by disabling the teleconsultation, e.g. aborted/ disconnected videocall sessions, connection issues, problems with sound or video) oHigh patient acceptance: =80% (patient satisfaction questionnaire) •Safety: similar rates of serious adverse events (SAEs) during the intervention (target: <10 % differences between groups) •Compliance: high percentage of the prescribed nutrition and exercise interventions carried out (target =70%) •Recruitment: confirmation of recruitment rates: (target: = 3 patients/ month)

Secondary

MeasureTime frame
Clinical outcomes will be evaluated in an exploratory manner with the perspective to gain first insights and to find a suitable outcome parameter for the planned follow-up study. Clinical outcomes include: 1. Longitudinal analysis of nutritional status, muscle mass, frailty, sarcopenia, physical and respiratory function, and quality of life at inclusion, before surgery and at hospital discharge 2. Mortality (hospital, 30 days), hospital and ICU-length of stay 3. Duration of mechanical ventilation, vasopressor treatment and renal replacement therapy 4. Number of complications

Countries

Germany

Contacts

Public ContactAileen Hill

Uniklinik RWTH Aachen, Klinik für Anästhesiologie

ahill@ukaachen.de+492418038166

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026